0001193125-22-149268.txt : 20220513 0001193125-22-149268.hdr.sgml : 20220513 20220513060632 ACCESSION NUMBER: 0001193125-22-149268 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220511 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20220513 DATE AS OF CHANGE: 20220513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLASE, INC CENTRAL INDEX KEY: 0000811240 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 870442441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36385 FILM NUMBER: 22920102 BUSINESS ADDRESS: STREET 1: 27042 TOWNE CENTRE DRIVE STREET 2: SUITE 270 CITY: FOOTHILL RANCH STATE: CA ZIP: 92610 BUSINESS PHONE: 949-361-1200 MAIL ADDRESS: STREET 1: 27042 TOWNE CENTRE DRIVE STREET 2: SUITE 270 CITY: FOOTHILL RANCH STATE: CA ZIP: 92610 FORMER COMPANY: FORMER CONFORMED NAME: BIOLASE TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER MEDICAL TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER ENDO TECHNIC CORP DATE OF NAME CHANGE: 19920708 8-K 1 d341048d8k.htm 8-K 8-K
BIOLASE, INC false 0000811240 0000811240 2022-05-11 2022-05-11

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 11, 2022

 

 

BIOLASE, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-36385   87-0442441
(State or Other Jurisdiction
of Incorporation)		  

(Commission

File Number)

   (IRS Employer
Identification No.)

27042 Towne Centre Drive,

Suite 270

Lake Forest, California

     92610
(Address of Principal Executive Offices)     (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (949) 361-1200

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange

on which registered

Common Stock, par value $0.001 per share   BIOL  

The NASDAQ Stock Market LLC

(NASDAQ Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 11, 2022, the Board of Directors (the “Board”) of Biolase, Inc. (the “Company”) made certain appointments to the Audit, Compensation, Nominating and Corporate Governance, and Clinical Committees of the Board.

Kathleen O’Loughlin and Kenneth Yale were appointed as members of the Audit Committee of the Board, Jonathan Lord remains on this committee, and Jess Roper remains the Chair of this committee. Carol Summerhays and Martha Somerman were appointed as members of the Compensation Committee, and Jonathan Lord remains the Chair of this committee. Kathleen O’Loughlin, Kenneth Yale, Carol Summerhays, and Martha Somerman were appointed to the Nominating and Corporate Governance Committee of the Board, Jess Roper remains on this committee, and Jonathan Lord remains Chair of this committee. Kathleen O’Loughlin, Kenneth Yale, and Carol Summerhays were appointed as members of the Clinical Committee of the Board, and Martha Somerman was appointed Chair.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    BIOLASE, INC.
Date: May 13, 2022     By  

/s/ John R. Beaver

    Name:   John R. Beaver
    Title:   President and Chief Executive Officer
 EX-101.SCH 2 biol-20220511.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 biol-20220511_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 biol-20220511_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information
May 11, 2022
Cover [Abstract]  
Entity Registrant Name BIOLASE, INC
Amendment Flag false
Entity Central Index Key 0000811240
Document Type 8-K
Document Period End Date May 11, 2022
Entity Incorporation State Country Code DE
Entity File Number 001-36385
Entity Tax Identification Number 87-0442441
Entity Address, Address Line One 27042 Towne Centre Drive
Entity Address, Address Line Two Suite 270
Entity Address, City or Town Lake Forest
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92610
City Area Code (949)
Local Phone Number 361-1200
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.001 per share
Trading Symbol BIOL
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 d341048d8k_htm.xml IDEA: XBRL DOCUMENT 0000811240 2022-05-11 2022-05-11 BIOLASE, INC false 0000811240 8-K 2022-05-11 DE 001-36385 87-0442441 27042 Towne Centre Drive Suite 270 Lake Forest CA 92610 (949) 361-1200 false false false false Common Stock, par value $0.001 per share BIOL NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d341048d8k.htm biol-20220511.xsd biol-20220511_lab.xml biol-20220511_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d341048d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d341048d8k.htm" ] }, "labelLink": { "local": [ "biol-20220511_lab.xml" ] }, "presentationLink": { "local": [ "biol-20220511_pre.xml" ] }, "schema": { "local": [ "biol-20220511.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "biol", "nsuri": "http://www.biolase.com/20220511", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d341048d8k.htm", "contextRef": "duration_2022-05-11_to_2022-05-11", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d341048d8k.htm", "contextRef": "duration_2022-05-11_to_2022-05-11", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.biolase.com//20220511/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001193125-22-149268-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-149268-xbrl.zip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�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